Yulian Pang

Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

CD38-NAD(+) Axis: New Insights into Glaucoma Therapy.

CD38-NAD(+) Axis: New Insights into Glaucoma Therapy.

Journal: Molecular neurobiology

Published: April 18, 2025

SIRT4 Protects Retina Against Excitotoxic Injury by Promoting OPA1-Mediated Müller Glial Cell Mitochondrial Fusion and GLAST Expression.

SIRT4 Protects Retina Against Excitotoxic Injury by Promoting OPA1-Mediated Müller Glial Cell Mitochondrial Fusion and GLAST Expression.

Journal: Investigative ophthalmology & visual science

Published: January 28, 2025

Rapamycin protects glucocorticoid-induced glaucoma model mice against trabecular meshwork fibrosis by suppressing mTORC1/2 signaling.

Rapamycin protects glucocorticoid-induced glaucoma model mice against trabecular meshwork fibrosis by suppressing mTORC1/2 signaling.

Journal: European journal of pharmacology

Published: August 07, 2024

CD38 Deficiency Protects Mouse Retinal Ganglion Cells Through Activating the NAD+/Sirt1 Pathway in Ischemia-Reperfusion and Optic Nerve Crush Models.

CD38 Deficiency Protects Mouse Retinal Ganglion Cells Through Activating the NAD+/Sirt1 Pathway in Ischemia-Reperfusion and Optic Nerve Crush Models.

Journal: Investigative ophthalmology & visual science

Published: May 22, 2024

Noninvasive Light Flicker Stimulation Promotes Optic Nerve Regeneration by Activating Microglia and Enhancing Neural Plasticity in Zebrafish.

Noninvasive Light Flicker Stimulation Promotes Optic Nerve Regeneration by Activating Microglia and Enhancing Neural Plasticity in Zebrafish.

Journal: Investigative ophthalmology & visual science

Published: May 01, 2024

Resveratrol Alleviates Retinal Ischemia-Reperfusion Injury by Inhibiting the NLRP3/Gasdermin D/Caspase-1/Interleukin-1β Pyroptosis Pathway.

Resveratrol Alleviates Retinal Ischemia-Reperfusion Injury by Inhibiting the NLRP3/Gasdermin D/Caspase-1/Interleukin-1β Pyroptosis Pathway.

Journal: Investigative ophthalmology & visual science

Published: December 22, 2023

Protective effect of the natural flavonoid naringenin in mouse models of retinal injury.

Protective effect of the natural flavonoid naringenin in mouse models of retinal injury.

Journal: European journal of pharmacology

Published: August 23, 2023

Therapeutic effects of low-color-temperature light-emitting diodes on dry eye.

Therapeutic effects of low-color-temperature light-emitting diodes on dry eye.

Journal: Journal of biophotonics

Published: May 23, 2023

Retinal microvasculature features in patients with migraine: a systematic review and meta-analysis.

Retinal microvasculature features in patients with migraine: a systematic review and meta-analysis.

Journal: Frontiers in neurology

Published: March 16, 2023

Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush.

Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush.

Journal: International immunopharmacology

Published: January 28, 2023

CD38 deficiency protects the retina from ischaemia/reperfusion injury partly via suppression of TLR4/MyD88/NF-κB signalling.

CD38 deficiency protects the retina from ischaemia/reperfusion injury partly via suppression of TLR4/MyD88/NF-κB signalling.

Journal: Experimental eye research

Published: November 14, 2021

Lollipop-Inspired Multilayered Drug Delivery Hydrogel for Dual Effective, Long-Term, and NIR-Defined Glaucoma Treatment.

Lollipop-Inspired Multilayered Drug Delivery Hydrogel for Dual Effective, Long-Term, and NIR-Defined Glaucoma Treatment.

Journal: Macromolecular bioscience

Published: May 12, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026